Back to search
Esophageal Variceal Rebleeding
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Esophageal Variceal Rebleeding trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Esophageal Variceal Rebleeding trials you may qualify forTransjugular intrahepatic portosystemic shunt (TIPS) is a key therapeutic intervention for complications of portal hypertension. However, the risk of post-proce…
We design a randomized trial to clarify the necessity of antibiotic prophylaxis for the patients chronic liver disease with gastric varices treated by elective…
SP by EUS-CYA improves clinical outcomes (eg, EV rebleeding) in patients with HCC and prior EV bleeding when compared with SP by EGD-VBL
Platinum-based compounds are associated with several adverse effects, including Porto-Sinusoidal Vascular Disease (PSVD). Therapeutic strategies for platinum-re…
Comparison of endoscopic therapy combined with non-selective therapy β Receptor blockers (NSBBs) and TIPS in the treatment of liver cirrhosis The impact of red…